To evaluate the effect of CD137L expression on PD-1high CD8+ T-cells function, the amount of CD39+CD103+ CD8+ TIL subsets was measured and demonstrated that an increased level of CD39+CD103+ is observed in CD137L positive cells, which is associated with activation of T-cells and tumor responsiveness. The gene discussed is ENTPD1; the disease is neoplasm.